- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
- Locations
-
- UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
Clinical trial condition
Stage IV Renal Cell Cancer
Explore clinical trials studying Stage IV Renal Cell Cancer. Study availability and eligibility vary by location and protocol.
63 public trials
1 recruiting study
Stage IV Renal Cell Cancer trial results
Active, not recruiting
Axitinib With or Without Anti-OX40 Antibody PF-04518600 in Treating Patients With Metastatic Kidney Cancer
NCT03092856
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
- Locations
-
- Los Angeles County-USC Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- USC Norris Oncology/Hematology-Newport Beach Newport Beach, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
Active, not recruiting
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
NCT03682289
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +43 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- University of California, San Francisco San Francisco, California, United States
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
Active, not recruiting
Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney Cancer
NCT01684397
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- The University of Kansas Cancer Center Westwood, Kansas, United States
- Karamanos Cancer Institute Detroit, Michigan, United States
- Roswell Park Cancer Institute Buffalo, New York, United States
- University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States
NCT02526511
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
- Locations
-
- Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
Completed
Ibrutinib and Nivolumab in Treating Patients With Previously-Treated Metastatic Kidney Cancer
NCT02899078
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
NCT01767636
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma of the Collecting Ducts of Bellini, +23 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Mayo Clinic Rochester, Minnesota, United States
NCT03154190
- Conditions
- Acute Myeloid Leukemia, Adenocarcinoma, Adnexal Diseases, +146 more
- Locations
-
- Virginia K Crosson Cancer Center Fullerton, California, United States
NCT00655655
- Conditions
- Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +70 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
NCT00019396
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +26 more
- Locations
-
- Surgery Branch Bethesda, Maryland, United States